Sonicates of mouse bone marrow-derived mast cells (BMMC) differentiated in vitro and of mouse serosal mast cells differentiated in vivo contained small but approximately equal amounts of aminopeptidase activity, as determined by cleavage of leucine-fl-naphthylamide and resolution of the reaction products by reverse-phase high-performance liquid chromatography. Aminopeptidase activity was exocytosed from antigen-activated, IgE-sensitized BMMC in proportion to the secretory granule enzyme (3-hexosaminidase, thereby localizing -60% of the total cell-associated aminopeptidase activity to the secretory granules of the mast cells. A prominent secretory granule location for aminopeptidase was confirmed by activity measurement in subcellular fractions of disrupted BMMC. The secretory granule aminopeptidase had a pH optimum of 6.0-8.0 and a Km of 0.36 ± 0.06 mM (mean + SD; n = 3) for leucine-I3-naphthylamide. When various amino acid j3-naphthylamides were used as substrates, the preference of the secretory granule enzyme was Ala > Leu > Phe >> Arg >> Asp = Tyr. Most of the aminopeptidase activity that was exocytosed from calcium ionophore-activated BMMC was bound to 35S-labeled proteoglycans in complexes of >1 x 107 kDa as dermed by exclusion during Sepharose CL-2B gel-filtration chromatography. We postulate that the aminopeptidase in the mast cell protease/proteoglycan complexes allows the removal of N-terminal amino acids from peptides that are generated by the action of mast cell endopeptidases.
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Rat and mouse mast cells contain in their secretory granules serine endopeptidases and the exopeptidase carboxypeptidase A (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . These proteases are active at neutral pH and are ionically linked in macromolecular complexes with acidically charged proteoglycans (1, 5, 6) . Mast cells can be characterized in part by their content of these proteases. For example, mouse serosal mast cells contain '150-fold more carboxypeptidase A in their secretory granules than interleukin 3-dependent, mouse bone marrow-derived progenitor mast cells (BMMC). We have shown that when BMMC are cocultured with fibroblasts, the BMMC differentiate to become more like serosal mast cells in histamine content, carboxypeptidase A content, and [355] heparin proteoglycan synthesis (6, 12) . We now identify and partially characterize a mouse mast cell exopeptidase that is located in the secretory granules ofBMMC and that has aminopeptidase activity. This aminopeptidase activity is present in approximately equal amounts in BMMC, BMMC cocultured with fibroblasts, and serosal mast cells.
MATERIALS AND METHODS
Isolation of Mouse Serosal Mast Cells and Culture of Mouse BMMC. Serosal mast cells (13, 14) were obtained from BALB/c mice (The Jackson Laboratory) by peritoneal lavage, purified to >90%, resuspended in Tyrode's buffer, sonicated, and stored frozen at -70'C until used. BMMC were obtained by culturing bone marrow cells from BALB/c mice for 3-6 wk in 50% enriched medium (RPMI 1640 medium containing 10% fetal bovine serum, penicillin at 100 units/ml, streptomycin at 100,ug/ml, 2 mM L-glutamine, 0.1 mM nonessential amino acids, and 5 mM Hepes) and 50%6 WEHI-3 conditioned medium (15) . In some experiments, BMMC were differentiated further by fibroblast coculture (16) . After 30 days, the mast cell/fibroblast cocultures were washed twice with calcium-and magnesium-free Hanks' balanced salt solution (HBSS), dispersed with trypsin, enriched to a purity of >94% mast cells by discontinuous metrizamide centrifugation (12) , resuspended at 1 x 106 cells per ml in HBSS, and sonicated.
Activation of Mouse BMMC. BMMC were sensitized with mouse monoclonal anti-dinitrophenyl IgE (17) in Tyrode's buffer with 0.05% gelatin and activated with 0-40 ng of dinitrophenyl conjugated to bovine serum albumin as described (18) . In some experiments, BMMC were activated with 0.5 ,M calcium ionophore A23187 (19) . After immunologic or calcium ionophore activation, the mast cells were pelleted by centrifugation, the supernatants were removed, and the cell pellets were resuspended in Tyrode's buffer and sonicated. The cytosolic enzyme lactate dehydrogenase (20) and the secretory granule enzymes fB-hexosaminidase (21) and mast cell carboxypeptidase A (6) were routinely quantitated in samples of supernatants and sonicated cell pellets. The net percentage release (4) (27) . To calculate the Ki (27) To determine the hydrodynamic size of the exocytosed aminopeptidase after removal of the ionically linked proteoglycans, the supernatant from 1 x 108 activated BMMC was made 5 M in NaCI and then applied to a column (0.8 x 2 cm) of phenyl-Sepharose CL-4B (Pharmacia) that had been previously equilibrated in 5 M NaCI/0.01 M Tris HCI, pH 7.2. BMMC proteoglycans do not bind to the phenyl-Sepharose CL-4B column under these high salt conditions (5). After the column was washed with 5 column vol of the high salt buffer, bound proteins were eluted with a low salt buffer of 0.15 M NaCI/0.01 M Tris-HCI, pH 7.2. A 1-ml sample ofthis material was applied at 4°C to a 0.8 x 80 cm column of Sephadex G-150 (Pharmacia) that had been equilibrated in the low salt Tris*HCI buffer. Fractions (0.5 ml) were collected and assessed for aminopeptidase activity using leucine-, 3- (29) , and lactate dehydrogenase activity.
RESULTS
Identification of Aminopeptidase Activity in Supernatants of Calcium Ionophore-Activated Mouse BMMC. When supernatants of calcium ionophore-activated BMMC were incubated for 0-60 min with leucine-13-naphthylamide, progressive degradation of the substrate occurred with the concurrent formation of a digestion product that had a retention time on RP-HPLC of 1.80 min, identical to that of the fB-naphthylamine standard. No measurable product was formed when leucine-f3-naphthylamide was incubated in the absence of the BMMC supernatants. In three determinations with separate cultures of BMMC and separate preparations of mouse serosal mast cells, 0.003 ± 0.002 (mean ± SD) and 0.002 ± 0.001 unit, respectively, of aminopeptidase activity was found per 106 sonicated cells. Cleavage of Ile-His-Pro-Phe by the proteases present in the supernatant of calcium ionophore-activated BMMC also occurred in a linear manner with time, resulting in the appearance of a digestion product that was His-Pro-Phe by amino acid analysis (data not shown).
Characterization of the Aminopeptidase Activity Exocytosed from Calcium Ionophore-Activated BMMC. Digestion of leucine-f3-naphthylamide was not inhibited by a pretreatment of the supernatant for 1 hr with 10 mM diisopropylfluorophosphate or 150 ,M potato carboxypeptidase A inhibitor. In contrast, when samples of the same supernatants were preincubated with 10 mM bathophenanthroline or 1 mM bestatin, the degradation of this substrate was inhibited 41% ± 3% or 91% ± 2% (mean ± SD; n = 3), respectively. This aminopeptidase possessed a broad pH optimum of 6.0-8.0, and the Km for the degradation of leucine-p-naphthylamide was 0.36 ± 0.06 mM (mean + SD; n = 3) in 0.02 M Tris buffer (pH 8.0) (data not shown). The presence of varied amounts of the inhibitor bestatin did not alter the Vmax of the reaction, indicating a competitive-type inhibition with a Ki of 1.0 ,uM (data not shown). To characterize the substrate preference of the exocytosed aminopeptidase, supernatants from calcium ionophore-activated BMMC were incubated with various amino acid P-naphthylamides. The preferred substrate was alanine-,B-naphthylamide, with the rate of cleavage of the leucine and phenylalanine derivatives being within the same order of magnitude (Table 1) .
To determine whether the aminopeptidase activity was released in association with proteoglycans, 35S-labeled BMMC were activated with calcium ionophore, and the resulting supernatant was filtered on a Sepharose CL-2B column. As shown in Fig. 1, 69% of the exocytosed aminopeptidase activity, 78% of the carboxypeptidase A activ- ity, and 7% of the 35S-labeled proteoglycans coeluted in the excluded volume of the column as a macromolecular complex of >107 kDa. The remaining aminopeptidase activity, carboxypeptidase A activity, and 15S-labeled proteoglycans eluted as broad peaks with Ka, = 0.81, 0.73, and 0.62, respectively. In three experiments (including that depicted in Fig. 1 ), 56% ± 12% (mean ± SD) of the exocytosed aminopeptidase activity, 74% ± 6% of the carboxypeptidase A activity, and 8.7% ± 5.6% of the 35S-labeled proteoglycans coeluted in the excluded volume of the Sepharose CL-2B column.
To separate the aminopeptidase activity from the proteoglycans in the macromolecular complex, the supernatant from calcium ionophore-activated BMMC was made 5 M in NaCl and applied to a phenyl-Sepharose column that retained all of the aminopeptidase activity. When the column was washed with the low salt buffer, 67% of the applied aminopeptidase activity was recovered. By Sephadex G-150 gel-filtration chromatography, the aminopeptidase eluted as a single peak with a mass of 237 ± 18 kDa (mean ± SD; n = 3; data not shown). After removal ofthe aminopeptidase from the proteoglycans, the pH optimum, Km for leucine-,jnaphthylamide, and the relative rates of cleavage of the various amino acid 83-naphthylamides were unchanged. Subcellular Localization of the Intracellular BMMC Aminopeptidase. IgE-sensitized BMMC were activated with antigen in a dose-dependent protocol to determine whether or not there was a direct relationship between the exocytosis of the aminopeptidase and the exocytosis of the secretory granule enzymes f-hexosaminidase and carboxypeptidase A. Linear regression analysis of the net percentage release of aminopeptidase versus that of f3-hexosaminidase (Fig. 2) revealed a slope of 0.59, a y intercept of -0.1%, and a correlation coefficient of 0.98 (n = 9), indicating that =60% of the total aminopeptidase in BMMC was stored in the secretory granules of the cells. The net percentage release of carboxypeptidase A was proportional to that of 8-hexosaminidase with a slope of 0.94, a y intercept of 0.0%, and a correlation coefficient of 0.98.
The subcellular location of the aminopeptidase in BMMC was also examined by analysis of Percoll density-gradient the histamine (Fig. 3) . The remainder of the aminopeptidase (22%) was located at the top of the Percoll gradient in a broad peak with 91% of the lactate dehydrogenase.
To determine whether aminopeptidase activity was present on the outer membrane of the BMMC, intact BMMC or whole cell sonicates were incubated with either Ile-His-ProPhe or hippuryl-L-phenylalanine in Tyrode's buffer to detect aminopeptidase and carboxypeptidase activities, respectively. The intact BMMC possessed 38% 8% (mean ± SD; n = 4) of the aminopeptidase activity of the sonicates of these cells. In contrast, intact BMMC expressed only 5.9o ± 2.9o (n = 4) of the carboxypeptidase A activity present in whole cell sonicates. Neither Ile-His-Pro-Phe nor hippuryl-L-phenylalanine caused a significant release from intact BMMC of the cytosolic marker lactate dehydrogenase or the granule marker /3-hexosaminidase when compared to buffer alone (average release of both constituents <6% in the presence of Ile-His-Pro-Phe, hippuryl-L-phenylalanine, or buffer). The amounts of aminopeptidase activity and carboxypeptidase A activity of whole cell sonicates assayed in the Tyrode's buffer were 101% and 84% (n = 1), respectively, of those obtained in the usual assay buffer for each substrate.
Effects of Fibroblast Coculture on the Aminopeptidase Activity of Mouse BMMC. After coculture of BMMC with 3T3 fibroblasts for 30 days, the adherent cells were treated with trypsin, and the mast cells were isolated to a purity of >94% by density-gradient centrifugation (n = 3). Aminopeptidase activity, carboxypeptidase A activity, and histamine were measured in starting BMMC and in the cocultured BMMC that had been separated from the fibroblasts. When compared to the starting cells, the cocultured BMMC did not display a significant increase in aminopeptidase activity but did have a 46-fold increase in carboxypeptidase A activity and a 21-fold increase in histamine (Table 2 ).
DISCUSSION
We have characterized an aminopeptidase activity that is stored within the secretory granules of mouse mast cells and is distinct from all other previously described mast cell neutral proteases. A relatively specific aminopeptidase substrate, leucine-/3-naphthylamide (22) , was readily cleaved, and this activity was inhibitable by the aminopeptidasespecific inhibitor bestatin (25) with a K, of 1 ,uM, but it was not inhibitable by the serine protease inhibitor diisopropylfluorophosphate or the potato-derived carboxypeptidase A inhibitor. The exocytosed aminopeptidase activity had a neutral pH optimum, a Km for leucine-,8-naphthylamide of 0.36 mM, and a preference for amino acid 8-naphthylamide substrates that had hydrophobic amino acids (Table 1) .
Two criteria were used to demonstrate that at least 60% of the aminopeptidase activity present in the BMMC was stored tMast cell carboxypeptidase A; mean + SD (n = 3). tAminopeptidase; mean + SD (n = 3).
in the secretory granules of the cells. First, upon haptenspecific activation of IgE-sensitized BMMC, the release of aminopeptidase activity (Fig. 2) was linearly proportional to the release of the secretory granule marker ,-hexosaminidase (18) with a correlation coefficient of 0.98 and a slope of 0.59, indicating that -6Wo of the aminopeptidase activity was contained in the secretory granules. Second, subcellular fractionation of a BMMC sonicate on a Percoll density gradient showed that 78% of the intracellular aminopeptidase activity was present in the secretory granule fractions, as defined by its cosedimentation with histamine and carboxypeptidase A (Fig. 3) . Because intact BMMC expressed =38% of the aminopeptidase activity of whole BMMC sonicates, it is likely that the aminopeptidase activity that is not in the BMMC secretory granules is on the outer cell membrane.
Mouse BMMC were cultured for 3-6 wk in the presence of 1o fetal bovine serum, and thus it is possible that these mast cells endocytosed and then concentrated a bovine aminopeptidase in their secretory granules. However, the fact that the amount of aminopeptidase activity in the peritoneal connective tissue mast cells was similar to that in the BMMC suggests that mast cells are the source of this exopeptidase.
We have shown that the BMMC carboxypeptidase A (6) and serine protease (5) activities are predominantly exocytosed in macromolecular complexes with secretory granule heparin and chondroitin sulfate E proteoglycans. Most of the aminopeptidase activity that was exocytosed from the calcium ionophore-activated BMMC coeluted with the macromolecular complexes of carboxypeptidase A and "5S-labeled proteoglycans (Fig. 1) . Because these complexes could be dissociated with 5 M NaCl, it is probable that the secretory granule aminopeptidase is ionically linked to proteoglycans. It was postulated (30) and subsequently demonstrated (31) that the close approximation of the chymotryptic serine protease (rat mast cell protease I) and the carboxypeptidase A in the protease/proteoglycan complexes of rat serosal mast cells enables sequential endopeptidase/carboxypeptidase cleavages of protein substrates. We postulate that the aminopeptidase in the protease/proteoglycan complexes allows removal of the newly exposed N-terminal amino acid from the peptide that is generated by the attack of the endopeptidase.
Coculture of BMMC with 3T3 fibroblasts causes the BMMC to become like serosal mast cells as defined by their ability to be stained by safranin, their increased rate of biosynthesis of [355] heparin proteoglycans, and their increased content of histamine and carboxypeptidase A (6, 12, 16) . We have again demonstrated that coculture of BMMC with 3T3 fibroblasts for 30 days causes the carboxypeptidase A and histamine contents of the BMMC to increase, and the increments in the present studies were 46-and 21-fold, respectively (Table 2) . Despite these increases, the aminopeptidase activity of the cocultured BMMC remained similar to that of the noncocultured BMMC (Table 2 ) and that of the serosal mast cells. Thus, the fibroblast microenvironment is selective in augmenting the constituents of the secretory granules of mouse mast cells, and this selectivity is compatible with the relative amounts of the constituents present in serosal mast cells as compared to BMMC.
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